Putnam Investments’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $315K | Sell |
2,589
-25,745
| -91% | -$2.87M | ﹤0.01% | 1083 |
|
|
2023
Q3 | $3.18M | Buy |
28,334
+2,303
| +9% | +$292K | ﹤0.01% | 575 |
|
|
2023
Q2 | $3.79M | Buy |
+26,031
| New | +$3.54M | 0.01% | 521 |
|
|
2022
Q1 | – | Sell |
-35,550
| Closed | -$4.38M | – | 1271 |
|
|
2021
Q4 | $4.38M | Buy |
35,550
+5,533
| +18% | +$724K | 0.01% | 587 |
|
|
2021
Q3 | $4.26M | Sell |
30,017
-80,790
| -73% | -$11.9M | 0.01% | 580 |
|
|
2021
Q2 | $17.3M | Sell |
110,807
-191,355
| -63% | -$31M | 0.03% | 274 |
|
|
2021
Q1 | $47M | Sell |
302,162
-43,694
| -13% | -$6.77M | 0.08% | 179 |
|
|
2020
Q4 | $51.7M | Buy |
345,856
+202,381
| +141% | +$28.6M | 0.09% | 165 |
|
|
2020
Q3 | $19M | Buy |
143,475
+25,614
| +22% | +$3.35M | 0.04% | 245 |
|
|
2020
Q2 | $13.7M | Sell |
117,861
-68,877
| -37% | -$7.94M | 0.03% | 280 |
|
|
2020
Q1 | $18.3M | Buy |
186,738
+9,025
| +5% | +$1.18M | 0.05% | 224 |
|
|
2019
Q4 | $25.8M | Sell |
177,713
-30,303
| -15% | -$4.18M | 0.05% | 232 |
|
|
2019
Q3 | $27.7M | Buy |
208,016
+37,595
| +22% | +$4.86M | 0.06% | 226 |
|
|
2019
Q2 | $19.5M | Sell |
170,421
-6,677
| -4% | -$782K | 0.04% | 256 |
|
|
2019
Q1 | $22M | Buy |
177,098
+175,101
| +8,768% | +$19.9M | 0.05% | 233 |
|
|
2018
Q4 | $201K | Sell |
1,997
-456
| -19% | -$51.3K | ﹤0.01% | 921 |
|
|
2018
Q3 | $313K | Sell |
2,453
-74
| -3% | -$8.8K | ﹤0.01% | 988 |
|
|
2018
Q2 | $273K | Sell |
2,527
-662
| -21% | -$72K | ﹤0.01% | 1009 |
|
|
2018
Q1 | $338K | Hold |
3,189
| – | – | ﹤0.01% | 996 |
|
|
2017
Q4 | $374K | Sell |
3,189
-221
| -6% | -$25K | ﹤0.01% | 986 |
|
|
2017
Q3 | $388K | Sell |
3,410
-309
| -8% | -$35.7K | ﹤0.01% | 1015 |
|
|
2017
Q2 | $464K | Sell |
3,719
-309
| -8% | -$36.6K | ﹤0.01% | 986 |
|
|
2017
Q1 | $478K | Sell |
4,028
-103
| -2% | -$11.7K | ﹤0.01% | 1115 |
|
|
2016
Q4 | $414K | Sell |
4,131
-309
| -7% | -$33.1K | ﹤0.01% | 1145 |
|
|
2016
Q3 | $561K | Buy |
4,440
+515
| +13% | +$63.6K | ﹤0.01% | 1111 |
|
|
2016
Q2 | $459K | Sell |
3,925
-153,985
| -98% | -$17.4M | ﹤0.01% | 1205 |
|
|
2016
Q1 | $16.3M | Sell |
157,910
-175,203
| -53% | -$16.9M | 0.04% | 337 |
|
|
2015
Q4 | $33.2M | Sell |
333,113
-103
| -0% | -$10.1K | 0.07% | 232 |
|
|
2015
Q3 | $30.4M | Sell |
333,216
-721
| -0.2% | -$72.3K | 0.07% | 238 |
|
|
2015
Q2 | $35.4M | Sell |
333,937
-541,617
| -62% | -$59.9M | 0.07% | 248 |
|
|
2015
Q1 | $99.9M | Sell |
875,554
-493,746
| -36% | -$56.3M | 0.2% | 114 |
|
|
2014
Q4 | $151M | Sell |
1,369,300
-450,504
| -25% | -$47.5M | 0.31% | 76 |
|
|
2014
Q3 | $178M | Buy |
1,819,804
+23,233
| +1% | +$2.29M | 0.38% | 64 |
|
|
2014
Q2 | $181M | Buy |
1,796,571
+394,029
| +28% | +$38.4M | 0.39% | 66 |
|
|
2014
Q1 | $129M | Buy |
1,402,542
+238,376
| +20% | +$22M | 0.29% | 84 |
|
|
2013
Q4 | $105M | Sell |
1,164,166
-53,817
| -4% | -$4.66M | 0.25% | 103 |
|
|
2013
Q3 | $97.1M | Sell |
1,217,983
-28,007
| -2% | -$2.2M | 0.26% | 102 |
|
|
2013
Q2 | $90.7M | Buy |
+1,245,990
| New | +$93.2M | 0.26% | 93 |
|
Other funds holding ZBH
Putnam Investments's ZBH Position: Q4 2023 in Review
Putnam Investments reduced its Zimmer Biomet (ZBH) stake by 91% in Q4 2023, selling an estimated $2.87M and leaving 2,589 shares worth $315K. The position accounts for ﹤0.01% of the portfolio, ranked #1083.
Putnam Investments first reported a position in ZBH in Q2 2013 and has held it in 38 quarters since. The position peaked at $181M in Q2 2014. 1,030 funds tracked by Wall St. Rank hold ZBH as of Q4 2023.
- Putnam Investments held 2,589 shares of Zimmer Biomet worth $315K as of Q4 2023.
- Putnam Investments sold 25,745 Zimmer Biomet shares in Q4 2023, an estimated $2.87M.
- Zimmer Biomet made up ﹤0.01% of Putnam Investments's portfolio in Q4 2023, its #1083 holding.
- Putnam Investments first reported a position in Zimmer Biomet in Q2 2013 and has held it in 38 quarters since.
- Putnam Investments's Zimmer Biomet position peaked at $181M in Q2 2014.
- 1,030 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2023.
Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.